MX352082B - Inactivacion viral utilizando un metodo mejorado de solvente-detergente. - Google Patents

Inactivacion viral utilizando un metodo mejorado de solvente-detergente.

Info

Publication number
MX352082B
MX352082B MX2013006832A MX2013006832A MX352082B MX 352082 B MX352082 B MX 352082B MX 2013006832 A MX2013006832 A MX 2013006832A MX 2013006832 A MX2013006832 A MX 2013006832A MX 352082 B MX352082 B MX 352082B
Authority
MX
Mexico
Prior art keywords
viral inactivation
improved solvent
detergent method
lipid
detergent
Prior art date
Application number
MX2013006832A
Other languages
English (en)
Other versions
MX2013006832A (es
Inventor
Felgenhauer Martin
Montandon Frederic
Farcet Maria
Mison Dominique
Original Assignee
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta Inc filed Critical Baxalta Inc
Publication of MX2013006832A publication Critical patent/MX2013006832A/es
Publication of MX352082B publication Critical patent/MX352082B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a métodos para inactivar un virus que contiene una cubierta de lípido y proteínas esencialmente libres de un virus que contiene una cubierta de lípido obtenidas de dichos métodos.
MX2013006832A 2010-12-15 2011-12-14 Inactivacion viral utilizando un metodo mejorado de solvente-detergente. MX352082B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42351210P 2010-12-15 2010-12-15
PCT/US2011/064960 WO2012082931A1 (en) 2010-12-15 2011-12-14 Viral inactivation using improved solvent-detergent method

Publications (2)

Publication Number Publication Date
MX2013006832A MX2013006832A (es) 2014-01-31
MX352082B true MX352082B (es) 2017-11-08

Family

ID=45476616

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013006832A MX352082B (es) 2010-12-15 2011-12-14 Inactivacion viral utilizando un metodo mejorado de solvente-detergente.

Country Status (18)

Country Link
US (2) US20120208982A1 (es)
EP (2) EP2651421A1 (es)
JP (1) JP6013360B2 (es)
KR (2) KR101921036B1 (es)
CN (2) CN103370072B (es)
AR (1) AR084301A1 (es)
AU (1) AU2011343811B2 (es)
BR (1) BR112013015113B1 (es)
CA (1) CA2821971A1 (es)
CO (1) CO6761367A2 (es)
EA (1) EA025783B1 (es)
IL (1) IL226926B (es)
MX (1) MX352082B (es)
MY (1) MY161252A (es)
NZ (1) NZ611994A (es)
SG (2) SG191184A1 (es)
TW (1) TWI557229B (es)
WO (1) WO2012082931A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014025771A2 (en) * 2012-08-06 2014-02-13 Biogen Idec Ma Inc. Methods and compositions for inactivating enveloped viruses
TWI641382B (zh) * 2013-01-31 2018-11-21 韓美藥品股份有限公司 於包含因子ｖｉｉ之組成物中使病毒失活之方法
CA2930687C (en) * 2013-11-15 2024-04-23 Genentech, Inc. Methods for viral inactivation using eco-friendly detergents
DE102015115024A1 (de) * 2015-09-08 2017-03-09 Schülke & Mayr GmbH Flüssigkonzentrat für die Konservierung von Kosmetika
CN109022377A (zh) * 2017-06-12 2018-12-18 舒泰神（北京）生物制药股份有限公司 一种杆状病毒表达系统中杆状病毒的灭活方法
MX2020000353A (es) * 2017-07-10 2020-08-17 Takeda Pharmaceuticals Co Metodos para incubar liquidos e inactivar virus.
EP3446710A1 (en) 2017-08-25 2019-02-27 Glenmark Pharmaceuticals S.A. Methods of inactivating viral contaminants
CN111511800B (zh) * 2017-10-30 2023-11-28 武田药品工业株式会社 灭活脂包膜病毒的环境相容性去污剂
US10934340B2 (en) 2018-03-21 2021-03-02 Baxalta Incorporated Separation of VWF and VWF propeptide by chromatographic methods
EP3941928A1 (en) * 2019-03-19 2022-01-26 Amgen Inc. Alternate detergents for viral inactivation
IL293529A (en) * 2019-12-12 2022-08-01 Lilly Co Eli Methods for viral inactivation by environmentally compatible detergents
WO2021197646A1 (de) * 2020-03-31 2021-10-07 Schülke & Mayr GmbH Wässrige octenidinhaltige zusammensetzung zur behandlung und/oder prävention einer exazerbation von erkrankungen infolge einer coronavirusinfektion
JP2024508712A (ja) * 2021-02-12 2024-02-28 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 試料溶解試薬組成物ならびにその製造方法およびその使用方法
WO2023052556A1 (en) 2021-09-30 2023-04-06 Ichnos Sciences SA Methods of inactivating viral contaminants with a mixture of solvent and detergent
KR102420201B1 (ko) * 2022-01-17 2022-07-13 주식회사 유이케미칼 인지질 외피 보유 바이러스 사멸기능을 가지는 친환경 방역 조성물
CN116272708B (zh) * 2023-03-16 2023-11-14 海南医学院 一种量子点-抗体复合物微球及其制备方法、应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378208B2 (en) * 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
US6319662B1 (en) * 1993-12-17 2001-11-20 Baxter International Inc. Method and apparatus for removing viral contaminants from a body fluid
EP1740285A4 (en) 2004-04-13 2007-07-04 Sangart Inc METHOD AND COMPOSITIONS FOR SIMULTANEOUS ISOLATION OF HEMOGLOBIN FROM RED BLOOD BODIES AND INACTIVATION OF VIRUSES

Also Published As

Publication number Publication date
KR101921036B1 (ko) 2018-11-21
BR112013015113A2 (pt) 2018-11-06
NZ611994A (en) 2015-04-24
CN103370072B (zh) 2016-02-03
AU2011343811B2 (en) 2015-04-16
MX2013006832A (es) 2014-01-31
EP3495385A1 (en) 2019-06-12
EA025783B1 (ru) 2017-01-30
CN105524162A (zh) 2016-04-27
US20170327559A1 (en) 2017-11-16
KR20130137663A (ko) 2013-12-17
CN105524162B (zh) 2021-04-27
EP2651421A1 (en) 2013-10-23
CN103370072A (zh) 2013-10-23
CO6761367A2 (es) 2013-09-30
KR101854310B1 (ko) 2018-05-04
SG191184A1 (en) 2013-07-31
WO2012082931A1 (en) 2012-06-21
JP6013360B2 (ja) 2016-10-25
MY161252A (en) 2017-04-14
KR20180049160A (ko) 2018-05-10
AR084301A1 (es) 2013-05-08
BR112013015113B1 (pt) 2023-01-31
EA201390856A1 (ru) 2013-12-30
AU2011343811A1 (en) 2013-05-09
US20120208982A1 (en) 2012-08-16
TWI557229B (zh) 2016-11-11
TW201233805A (en) 2012-08-16
SG10201509994PA (en) 2016-01-28
JP2014501247A (ja) 2014-01-20
CA2821971A1 (en) 2012-06-21
IL226926B (en) 2020-05-31

Similar Documents

Publication Publication Date Title
MX352082B (es) Inactivacion viral utilizando un metodo mejorado de solvente-detergente.
IL251400B (en) Method for removing solvent-detergent (s/d) from s/d viral inactivated biological liquid preparations and viral safe preparations made thereby
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
UA116087C2 (uk) Композиція для лікування вірусу гепатиту c
MX2013011479A (es) Anticuerpos anti-fgfr4 y metodos de uso.
EA201390190A1 (ru) Ингибиторы вируса гепатита с
SG10201804385YA (en) Stimulus responsive polymers for the purification of biomolecules
IN2014CN00688A (es)
MX2014004022A (es) Anticuerpos anti-htra1 y metodos de uso.
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
MX2013001237A (es) Compuestos inhibidores del virus de la hepatitis c.
MX2013002255A (es) Moduladores de proteina de notum y metodos de uso.
EA201391152A1 (ru) Ингибиторы вируса гепатита с
MX2013001473A (es) Anticuerpos contra il-18r1 y usos de los mismos.
ZA201205547B (en) Therapies for treating hepatitis c virus infection
EP2588121A4 (en) C5A ANALOGUES AND METHODS OF USE THEREOF
MX336323B (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
IN2014KN02769A (es)
IN2012DN01849A (es)
AU2013318309A8 (en) Methods for treating hepatitis C
GB201114633D0 (en) Anti-viral therapy
NZ603431A (en) Parapoxvirus vectors containing rabies virus antigen
EP3599247A3 (en) Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
MX2019006336A (es) Metodos para la inactivacion viral y de otros agentes adventicios.
TN2013000397A1 (en) Treatment of hepatitis c virus infection with alisporivir

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: BAXALTA INCORPORATED

FG Grant or registration